Table 4.

Adverse events possibly or probably related to the treatment regimen

Patient*	Grade 1	Grade 2
A	None	None
B	None	None
D	None	None
F	Chills, myalgias, and shortness of breath (all during IL-2 treatment)	Injection site skin reaction (during IL-2 treatment)
G	None	Injection site skin reaction (during IL-2 treatment)
H	Dysgeusia, fatigue, diaphoresis, and injection site skin reactions (all during IL-2 treatment)	Flulike syndrome (during IL-2 treatment)
I	Malaise/fatigue, chills, injection site reactions, and dyspnea (all during IL-2 treatment)	Fever (during IL-2 treatment)

None of the patients experienced any grade 3 or grade 4 events.

^*Patients C and E are omitted because they did not receive T-cell infusions.